InvestorsHub Logo
Followers 3311
Posts 33124
Boards Moderated 1
Alias Born 06/29/2011

Re: What IS post# 47123

Thursday, 10/27/2016 2:07:00 AM

Thursday, October 27, 2016 2:07:00 AM

Post# of 100423
Read:


This is what Fit* was trying to do. Here is a PR of that in 2014

they failed unfortunately and had a 58k facility...we have a 50k one that is already pre-approved which they could never get.

Part of the pr- CEN Biotech, working under the inspection and authority of Health Canada, has completed the extraordinary governmental processes in Canada to receive approval to begin constructing their state of the art medical marijuana facility in the City of Lakeshore, Ontario, Canada. This is commonly referred to as the "Ready to Build" stage. The facility has undergone extensive vetting by authorities to ensure strict compliance and facility security requirements of Canadian Government and provincial requirements in Canada. Importantly, the facility has been graciously embraced by the town of Lakeshore and the Windsor Essex Economic Development Authorities as a most desirable source of jobs and economic activity for this highly agricultural region. This production facility is expected to have the capacity to produce up to 1.3 million pounds of dried medical marijuana annually, and the total may include capacity that is set aside for import and export. While facility construction has commenced, as of the date of this release CEN Biotech has to next secure the final and formal permissions (License) to grow, harvest, package, and sell medical marijuana in Canada or for export. ............................. Furthermore, if and when CEN Biotech achieves cumulative manufacturing and sales volume of one million pounds of cannabis, OGI will be entitled to a $100 million payment. In exchange for the rights listed above, and others, GrowLife will issue to designated CEN Biotech shareholders a total of 235,294,118 shares of restricted GrowLife common stock, the equivalent of $40 million at $0.17 per share, after CEN Biotech is formally approved to produce and harvest cannabis by the appropriate Canadian authorities.



FITX has long been locked in a battle with HC to get their subsidiary CEN Biotech licensed so they can build out their planned ”58,000 sq. ft. building in Lakeshore, Ontario, Canada to grow pot and make the property the largest, most advanced medical marijuana grow facility on earth.”

Health Canada rejected the CEN Biotech application which put an end to that dream. The Company launched a Judicial Review and Writ of Mandamus in order to compel Health Canada to issue them a growing license but these are desperate measures that rarely succeed.